EPS Bio Technology Corp. (TPEX:4183)

EPS Bio Technology Revenue

In the year 2025, EPS Bio Technology had annual revenue of 499.70M TWD with 10.78% growth. EPS Bio Technology had revenue of 119.21M in the quarter ending December 31, 2025, with 2.16% growth.

• Revenue: 499.70M
• Revenue Growth: +10.78%
• P/S Ratio: 0.76
• Revenue / Employee: 4.58M
• Employees: 109
• Market Cap: 380.80M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	499.70M	48.62M	10.78%
Dec 31, 2024	451.08M	-19.08M	-4.06%
Dec 31, 2023	470.17M	6.72M	1.45%
Dec 31, 2022	463.45M	-16.83M	-3.50%
Dec 31, 2021	480.28M	2.68M	0.56%